Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
CDSCO
Health Ministry Calls Media Report On Covid-19 Vaccine Side Effects 'Ill-Informed And Erroneous'
Swarajya Staff
Jan 17, 2023 03:33 PM +05:30 IST
CDSCO, State Drugs Administration Begin Joint Inspection Of Drug Manufacturing Units
Swarajya Staff
Dec 27, 2022 04:13 PM +05:30 IST
Each Dose Of Covaxin, Covishield Likely To Be Capped At Rs 275 After Getting Regular Market Approval
PTI
Jan 26, 2022 03:42 PM +05:30 IST
Guidelines On Covaxin For 15-18 Age Group Do Not Mention EUL By WHO: Govt Slams 'Ill-Informed, Misleading' Media Reports
Swarajya Staff
Jan 7, 2022 03:32 PM +05:30 IST
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
Swarajya Staff
Aug 25, 2021 11:00 AM +05:30 IST
Govt's Expert Panel Likely To Take Up Applications For Three More COVID-19 Vaccines This Week
Swarajya Staff
Aug 17, 2021 08:45 AM +05:30 IST
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: Report
Swarajya Staff
Jun 29, 2021 02:43 PM +05:30 IST
India's Drug Regulator Issues Guidelines To Clear Way For Import Of Foreign Produced COVID-19 Vaccines
Swarajya Staff
May 5, 2021 10:04 AM +05:30 IST
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India
Swarajya Staff
Apr 30, 2021 10:24 AM +05:30 IST
Govt To Provide Import Licences, Registration Certificate For Foreign Vaccines Within Three Days Of Emergency Use Approval
Swarajya Staff
Apr 16, 2021 09:57 AM +05:30 IST
Indian Drug Regulator's Expert Panel Recommends Phase 1 Trial Of Bharat Biotech's Intranasal Covid-19 Vaccine
IANS
Jan 20, 2021 09:19 AM +05:30 IST
COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine Candidate
IANS
Dec 24, 2020 08:13 AM +05:30 IST
ICMR Gets CDSCO Approval For Clinical Trial Of Convalescent Plasma In Covid-19 Patients
Swarajya Staff
Apr 18, 2020 01:38 PM +05:30 IST
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
Karan Bhasin
Apr 16, 2020 03:50 PM +05:30 IST
Load More